ArticleLangenbeck's archives of surgery2026
Survival benefit of surgical resection in elderly patients with extrahepatic cholangiocarcinoma: a propensity score-matched analysis.
Article in Langenbeck's archives of surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeExtrahepatic cholangiocarcinoma (eCCA) predominantly affects elderly patients, yet robust evidence evaluating surgical effectiveness in this population remains limited. This study aimed to determine the independent survival benefit of surgical resection in elderly patients with eCCA using propensity score matching to minimize selection bias.
methodPatients aged ≥ 65 years with non-metastatic eCCA diagnosed between 2010 and 2017 were identified from the SEER database. One-to-one propensity score matching (caliper 0.05 SD) balanced baseline characteristics between surgical (n = 682) and non-surgical (n = 617) groups, yielding 184 matched pairs. Overall survival (OS) and cancer-specific survival (CSS) were compared using Kaplan-Meier analysis and multivariable Cox regression.
resultsIn the matched cohort, surgical resection was associated with significantly improved survival for both endpoints. For OS: median survival was 29 vs 8 months (HR = 0.336, 95% CI: 0.267-0.423, P < 0.001), with 5-year OS rates of 25.3% vs 4.6%. For CSS: median survival was 36 vs 8 months (HR = 0.307, 95% CI: 0.237-0.396, P < 0.001), with 5-year CSS rates of 34.5% vs 7.4%. Surgical benefit remained consistent across all age strata (65-74y: HR = 0.32; 75-84y: HR = 0.29; ≥ 85y: HR = 0.34), with no age interaction (P = 0.89). Tumor stage modified treatment effect (P = 0.012), with greater benefit in T1-2 (HR = 0.27) than T3-4 disease (HR = 0.40), though both groups benefited significantly.
conclusionSurgical resection was associated with substantial survival benefit in elderly patients with non-metastatic, resectable eCCA, with approximately 66% reduction in mortality risk persisting across all age groups including octogenarians. Chronological age alone should not preclude surgical evaluation; decisions should incorporate comprehensive geriatric assessment and tumor biology.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.